Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-[[(2R)-2-hydroxy-2-methyl-3-butyn-1-yl]oxy]-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]- manufacturers
- Resencatinib
-
- $1970.00
-
2026-07-27
- CAS:2546117-79-5
- Purity:
- Supply Ability: 10g
|
| | Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-[[(2R)-2-hydroxy-2-methyl-3-butyn-1-yl]oxy]-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]- Basic information |
| | Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-[[(2R)-2-hydroxy-2-methyl-3-butyn-1-yl]oxy]-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]- Chemical Properties |
| density | 1.33±0.1 g/cm3(Predicted) | | pka | 11.97±0.29(Predicted) |
| | Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-[[(2R)-2-hydroxy-2-methyl-3-butyn-1-yl]oxy]-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]- Usage And Synthesis |
| Description | Resencatinib is a tyrosine kinase inhibitor with potential as an antineoplastic agent. | | Uses | Resencatinib is a potent tyrosine kinase inhibitor with antineoplastic activity[1]. Resencatinib is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | | References | [1] WHO Drug Information-World Health Organization (WHO). |
| | Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-[[(2R)-2-hydroxy-2-methyl-3-butyn-1-yl]oxy]-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]- Preparation Products And Raw materials |
|